Medication regimens using mifepristone and misoprostol are safe and effective for outpatient
treatment of early pregnancy loss for up to 84 days' gestation and for medication abortion up …

Background Mifepristone and a prostaglandin have been used successfully to terminate
pregnancy in Europe and China. We report the results of a large US study of mifepristone …

Mifepristone at a dose of 600 mg followed by 400 μg misoprostol orally has been used for
early abortion by hundreds of thousands of women with success rates at≤ 49 days' …

Background and Methods The combination of mifepristone (RU 486) and a prostaglandin
analogue given either intramuscularly or intravaginally is effective in terminating early …

The combination of mifepristone, an antiprogesterone known in the United States as
Mifeprex (Danco Laboratories, New York, NY), and misoprostol, a pro-staglandin analogue …

OBJECTIVE: To review the efficacy and safety of mifepristone (with misoprostol) for the
termination of early pregnancy. DATA SOURCES: A MEDLINE search (1966–October 2000) …

In the first 18 months since mifepristone was approved by the Food and Drug Administration
(FDA) for use with misoprostol for early medical abortion, approximately 80,000 women …

Objectives To evaluate whether the regimen of oral mifepristone and misoprostol for medical
abortion is acceptable to women and providers, in the United States, including physicians …

The combination of 200mg of mifepristone followed by 25μg to 800μg (depending on
gestational age) of misoprostol has been shown to be effective for the termination of …

Objectives To determine the time interval between mifepristone and misoprostol
administration associated with the most efficacious early pregnancy loss (EPL) …